Sept. 12, 2024 – The number of U.S. adults who have a potentially dangerous irregular heartbeat called atrial fibrillation is triple the number that health experts previously thought ...

Atrial fibrillation, a rapid, irregular heartbeat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5% of the population, or 10.5 million ...

PHONE TO GET NEW INFORMATION. SEPTEMBER IS A-FIB AWARENESS MONTH IF YOU DIDN’T KNOW. ATRIAL FIBRILLATION IS AN ABNORMAL HEARTBEAT CONDITION. EXPERTS SAY. NOW THAT PEOPLE ARE LIVING LONGER ...

Share on Pinterest New research suggests that there may be more than 10.5 million people in the United States living with atrial fibrillation, that is, three times more cases than experts had ...

An estimated 5% of the population -- 10.5 million U.S. adults -- have atrial fibrillation, according to new estimates from the University of California, San Francisco (UCSF). Advertisement ...

Atrial fibrillation, or afib, is an abnormal rhythm of the upper chambers of the heart that causes the heart to beat much faster than normal. This creates an irregular heartbeat ( arrhythmia), and ...

Smokers who make the decision to quit will see almost immediate health benefits, including a quick drop in their risk for atrial fibrillation, new research shows. "The findings provide a ...

LOUISVILLE, Ky. (WAVE) - September is National Atrial Fibrillation Awareness Month. Better known as A-Fib, it’s the most common form of an irregular heartbeat, affecting more than 37 million people ...

LONDON — Updated guidelines for the management of atrial fibrillation released by the European Society of Cardiology are revamping the approach to care for this complex, multifactorial disease.

Stroke prevention with direct-acting oral anticoagulant agents in patients with atrial fibrillation confers a risk of bleeding and limits their use. Asundexian, an activated factor XI (XIa ...

Despite consistent recommendations from clinical guidelines, data from randomized trials on a long-term antithrombotic treatment strategy for patients with atrial fibrillation and stable coronary ...